Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes

Low 25-hydroxyvitamin D levels correlate with the prevalence of diabetes; however, the mechanisms remain uncertain. Here, we show that nutritional deprivation–responsive mechanisms regulate vitamin D metabolism. Both fasting and diabetes suppressed hepatic cytochrome P450 (CYP) 2R1, the main vitamin D 25-hydroxylase responsible for the first bioactivation step. Overexpression of coactivator peroxisome proliferator–activated receptor γ coactivator 1-α (PGC-1α), induced physiologically by fasting and pathologically in diabetes, resulted in dramatic downregulation of CYP2R1 in mouse hepatocytes in an estrogen-related receptor α (ERRα)–dependent manner. However, PGC-1α knockout did not prevent fasting-induced suppression of CYP2R1 in the liver, indicating that additional factors contribute to the CYP2R1 repression. Furthermore, glucocorticoid receptor (GR) activation repressed the liver CYP2R1, suggesting GR involvement in the regulation of CYP2R1. GR antagonist mifepristone partially prevented CYP2R1 repression during fasting, suggesting that glucocorticoids and GR contribute to the CYP2R1 repression during fasting. Moreover, fasting upregulated the vitamin D catabolizing CYP24A1 in the kidney through the PGC-1α-ERRα pathway. Our study uncovers a molecular mechanism for vitamin D deficiency in diabetes and reveals a novel negative feedback mechanism that controls crosstalk between energy homeostasis and the vitamin D pathway.

[1]  D. Kiel,et al.  Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis. , 2018, American journal of human genetics.

[2]  N. Napoli,et al.  Vitamin D and Diabetes Mellitus. , 2018, Frontiers of hormone research.

[3]  P. O’Reilly,et al.  Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels , 2018, Nature Communications.

[4]  S. Virtanen,et al.  Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity , 2017, Diabetes.

[5]  M. Levine,et al.  CYP2R1 mutations causing vitamin D-deficiency rickets , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Glenville Jones,et al.  Vitamin D–Dependent Rickets Type 1B (25‐Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition? , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Michael F. Holick,et al.  The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention , 2017, Reviews in Endocrine and Metabolic Disorders.

[8]  Zhan Yin,et al.  Fatty Acid Oxidation in Zebrafish Adipose Tissue Is Promoted by 1α,25(OH)2D3. , 2017, Cell reports.

[9]  I. Goldstein,et al.  Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response. , 2017, Genome research.

[10]  M. Abbas Physiological functions of Vitamin D in adipose tissue , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  Tao Liu,et al.  Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse , 2016, Nucleic Acids Res..

[12]  Fabin Dang,et al.  Fasting and Feeding Signals Control the Oscillatory Expression of Angptl8 to Modulate Lipid Metabolism , 2016, Scientific Reports.

[13]  Gerhard K. H. Przemeck,et al.  Bezafibrate Improves Insulin Sensitivity and Metabolic Flexibility in STZ-Induced Diabetic Mice , 2016, Diabetes.

[14]  H. Duan,et al.  PGC-1α, glucose metabolism and type 2 diabetes mellitus. , 2016, The Journal of endocrinology.

[15]  P. Dhawan,et al.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. , 2016, Physiological reviews.

[16]  Kyoung-Jae Won,et al.  Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo , 2015, Genome research.

[17]  M. Levine,et al.  CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency. , 2015, The Journal of clinical endocrinology and metabolism.

[18]  A. Prentice,et al.  25(OH)D2 Half-Life Is Shorter Than 25(OH)D3 Half-Life and Is Influenced by DBP Concentration and Genotype , 2014, The Journal of clinical endocrinology and metabolism.

[19]  M. D. de Angelis,et al.  Liver adapts mitochondrial function to insulin resistant and diabetic states in mice. , 2014, Journal of hepatology.

[20]  B. Zinman,et al.  Prospective association of 25(OH)D with metabolic syndrome , 2014, Clinical endocrinology.

[21]  J. Auwerx,et al.  Vitamin D and energy homeostasis—of mice and men , 2014, Nature Reviews Endocrinology.

[22]  C. Mathieu,et al.  Vitamin D and diabetes: the odd couple , 2013, Trends in Endocrinology & Metabolism.

[23]  H. DeLuca,et al.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo , 2013, Proceedings of the National Academy of Sciences.

[24]  S. Burgess,et al.  Liver-Specific PGC-1beta Deficiency Leads to Impaired Mitochondrial Function and Lipogenic Response to Fasting-Refeeding , 2012, PloS one.

[25]  Michael Snyder,et al.  A highly integrated and complex PPARGC1A transcription factor binding network in HepG2 cells , 2012, Genome research.

[26]  D. Russell,et al.  Mutation of the CYP2R1 vitamin D 25-hydroxylase in a Saudi Arabian family with severe vitamin D deficiency. , 2012, The Journal of clinical endocrinology and metabolism.

[27]  H. DeLuca,et al.  Vitamin D 25-hydroxylase - Four decades of searching, are we there yet? , 2012, Archives of biochemistry and biophysics.

[28]  Glenville Jones,et al.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.

[29]  JoAnn E Manson,et al.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. , 2012, Endocrine reviews.

[30]  S. Kersten,et al.  Energy-sensing Factors Coactivator Peroxisome Proliferator-activated Receptor γ Coactivator 1-α (PGC-1α) and AMP-activated Protein Kinase Control Expression of Inflammatory Mediators in Liver , 2011, The Journal of Biological Chemistry.

[31]  M. Melamed,et al.  Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. , 2011, The Journal of clinical endocrinology and metabolism.

[32]  T. Spector,et al.  Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes , 2011, Diabetes.

[33]  I. Schuster Cytochromes P450 are essential players in the vitamin D signaling system. , 2011, Biochimica et biophysica acta.

[34]  J. Chou,et al.  Sexually Dimorphic Actions of Glucocorticoids Provide a Link to Inflammatory Diseases with Gender Differences in Prevalence , 2010, Science Signaling.

[35]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[36]  J. Hakkola,et al.  Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver. , 2010, Chemical research in toxicology.

[37]  Michelle Chan,et al.  Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. , 2009, Endocrinology.

[38]  Satu Arpiainen,et al.  Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes. , 2008, Toxicology and applied pharmacology.

[39]  C. Zechner,et al.  Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. , 2008, Genes & development.

[40]  K. Badenhoop,et al.  CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans , 2007, Diabetes/metabolism research and reviews.

[41]  E. Lobenhofer,et al.  Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. , 2006, Molecular cell.

[42]  R. Savkur,et al.  Coactivation of the Human Vitamin D Receptor by the Peroxisome Proliferator-Activated Receptor γ Coactivator-1 α , 2005, Molecular Pharmacology.

[43]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[44]  R. Savkur,et al.  Coactivation of the human vitamin D receptor by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha. , 2005, Molecular pharmacology.

[45]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[46]  Jiandie D. Lin,et al.  Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice , 2004, Cell.

[47]  C. Kellendonk,et al.  Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. , 2004, Molecular endocrinology.

[48]  Jeffrey B. Cheng,et al.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Anastasia Kralli,et al.  The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor α (ERRα)* , 2003, The Journal of Biological Chemistry.

[50]  D. Knutti,et al.  The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). , 2003, The Journal of biological chemistry.

[51]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[52]  I. Björkhem,et al.  Short-term starvation increases calcidiol-24-hydroxylase activity and mRNA level in rat kidney. , 1994, European journal of endocrinology.

[53]  M. Ståhlberg,et al.  Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse. , 1990, Biochemical pharmacology.

[54]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.